Certified by Founder Lodge 
                                        
                                        Viking Global Investors
 
                                                 United States  -  Greenwich, Connecticut 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $401,000,000
                                            27 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Viking Global Investors LP (“Viking”) is a global investment firm founded in 1999.  We employ a fundamentals-driven investment approach to managing over $40 billion of capital across long/sho
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   ID.me | 
                                                            April, 12 ,2023 | Series D | $132,000,000 | 
   Arctic Wolf | 
                                                            October, 06 ,2022 | Unknown | $401,000,000 | 
   Abdera Therapeutics | 
                                                            April, 24 ,2023 | Series B | $142,000,000 | 
   Ensoma | 
                                                            February, 06 ,2023 | Series B | $85,000,000 | 
   Solarea Bio | 
                                                            May, 09 ,2023 | Series B | $15,000,000 | 
   AlphaSense | 
                                                            June, 15 ,2022 | Series D | $225,000,000 | 
   Pragma Bio | 
                                                            March, 27 ,2023 | Unknown | $10,000,000 | 
   Lightmatter | 
                                                            June, 01 ,2023 | Series C | $154,000,000 | 
   Global Processing Services | 
                                                            January, 13 ,2022 | Unknown | $100,000,000 | 
   DermBiont, Inc. | 
                                                            October, 25 ,2023 | Series B | $35,200,000 | 
   ID.me | 
                                                            April, 12 ,2023 | Series D | $132,000,000 | 
   Triveni Bio | 
                                                            October, 27 ,2023 | Series A | $92,000,000 | 
   Abdera Therapeutics | 
                                                            April, 24 ,2023 | Series B | $142,000,000 | 
   HI-Bio | 
                                                            January, 05 ,2024 | Series B | $95,000,000 | 
   Solarea Bio | 
                                                            May, 09 ,2023 | Series B | $15,000,000 | 
   Valsoft Corporation | 
                                                            January, 22 ,2024 | Unknown | $170,000,000 | 
   Lightmatter | 
                                                            June, 01 ,2023 | Series C | $154,000,000 | 
   Sionna Therapeutics | 
                                                            March, 07 ,2024 | Series C | $182,000,000 | 
   DermBiont, Inc. | 
                                                            October, 25 ,2023 | Series B | $35,200,000 | 
   Antheia, Inc. | 
                                                            July, 23 ,2024 | Unknown | $17,000,000 | 
   Triveni Bio | 
                                                            October, 27 ,2023 | Series A | $92,000,000 | 
   Metsera | 
                                                            November, 14 ,2024 | Series B | $215,000,000 | 
   HI-Bio | 
                                                            January, 05 ,2024 | Series B | $95,000,000 | 
   Valsoft Corporation | 
                                                            January, 22 ,2024 | Unknown | $170,000,000 | 
   Sionna Therapeutics | 
                                                            March, 07 ,2024 | Series C | $182,000,000 | 
   Antheia, Inc. | 
                                                            July, 23 ,2024 | Unknown | $17,000,000 | 
   Metsera | 
                                                            November, 14 ,2024 | Series B | $215,000,000 | 
                                                
  ID.me
  Arctic Wolf
  Abdera Therapeutics
  Ensoma
  Solarea Bio
  AlphaSense
  Pragma Bio
  Lightmatter
  Global Processing Services
  DermBiont, Inc.
  Triveni Bio
  HI-Bio
  Valsoft Corporation
  Sionna Therapeutics
  Antheia, Inc.
  Metsera
dezerv.
 
                                            
FalconX
Kristal.AI
 
                                            
Finary
 
                                            
Savart
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)